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Brief CommunicationsConcomitant bilateral lung volume reduction surgery and aortic
valve replacement: Multidisciplinary strategies in achieving
a successful outcome
Cliff K. Choong, FRCS, FRACS,a,b Yasir Abu-Omar, DPhil, MRCS,b Ajit Agarwal, FRCP,c Thomas Pulimood, FRCP,d
Nicholas Screaton, FRCR,e Ian Hardy, FRCA,f Alain Vuylsteke, PhD, FRCA,f and Michael Davies, FRCP,g Cambridge and
Bury St Edmunds, United KingdomSignificant cardiac comorbidity is generally considered
a contraindication for lung volume reduction surgery
(LVRS). We described a multidisciplinary approach that
led to the successful management of a 53-year-old woman
with severe aortic stenosis who had a forced expiratory vol-
ume in 1 second (FEV1) of 20% predicted secondary to
smoking-related end-stage emphysema.
CLINICAL SUMMARY
A 53-year-old woman was referred for aortic valve re-
placement (AVR). She had symptomatic (angina and dizzy
spells) severe aortic stenosis (aortic valve area 0.8 cm2,
echocardiographic peak gradient 93 mm Hg, mean gradient
62 mm Hg), moderate aortic regurgitation, left ventricular
hypertrophy, and left ventricular dysfunction. She had
poor pulmonary function secondary to severe emphysema
(Table 1) with marked functional limitation affecting daily
activities and necessitating domiciliary oxygen therapy (Ta-
ble 1). She had stopped smoking 12 months previously, was
motivated to improve, and had good family support. Her
emphysema was heterogenous in distribution with predom-
inant upper-lobe involvement. Her coronary arteries were
free of obstructive disease on angiogram, and she had no
other significant comorbidity. She consented to concomitant
bilateral LVRS and AVR. A thoracic epidural catheter was
placed 4 hours before the scheduled surgery to minimize
the risk of epidural hematoma related to the impending sys-
temic anticoagulation required for cardiopulmonary bypass
(CPB) to replace the valve. A double-lumen endotracheal
tube was utilized, and the surgery was performed via
a median sternotomy. The aortic valve was replaced using
a 23-mm stented tissue valve. Following the AVR, while
still on CPB, pleural adhesions on the deflated lungs were
divided using electrocautery. The patient was then weaned
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ing satisfactory cardiorespiratory stability and hemostasis,
the LVRS proceeded with the left followed by the right
lung utilizing single-lung ventilation. Approximately 30%
of each lung was removed using a stapler buttressed with bo-
vine pericardium. Following surgery, the patient underwent
a planned early extubation. Adequate analgesia and regular
physiotherapy were ensured during the postoperative period.
There was minimal air leakage, and the chest drains were re-
moved on postoperative day 4. The patient was discharged
on postoperative day 8. At 4-month follow-up, she had
a marked improvement in her quality of life (QOL), func-
tional status, and pulmonary function measurements and
no longer required oxygen therapy (Table 1).
TABLE 1. Symptoms and pulmonary function measurements before
and after surgery
Preoperative
baseline
4-mo
postoperative
Percentage
improvement
NYHA symptoms Class III Class I
Modified Medical
Research Council
Dyspnea
Scale (degree of
dyspnea)
Category 4
(severe)
Category 1
(slight)
SF-36 Physical
Function Score
20 70
Supplemental
oxygen therapy
15 h/d None
FEV1, L
(% predicted)
0.44 L (20) 0.85 L (38) 93
FVC, L
(% predicted)
1.42 L (54) 2.35 L (89) 65
TLCO mmol CO $
kPa1 $ min1, L
(% predicted)
2.09 (28) 3.39 (46) 62
FRC, L (% predicted) 5.19 L (204) 2.90 L (114) 44
RV, L (% predicted) 4.47 L (267) 1.81 L (108) 60
TLC, L (% predicted) 6.27 L (139) 4.16 L (92) 34
RV/TLC (%) 71 44 38
6-minute walk (m) 190 432 127
Oxygen saturation
on room air (%)
89 97 9
NYHA, New York Heart Association; SF-36, Short Form–36; FEV1, forced expiratory
volume in 1 second; FVC, forced vital capacity; TLCO, transfer factor for carbon mon-
oxide;FRC, functional residual capacity;RV, residual volume; TLC, total lung capacity.rdiovascular Surgery c Volume 137, Number 6 1551
Brief CommunicationsDISCUSSION
LVRS has been shown to improve the QOL, respiratory
physiology, and survival in highly selected patients.1,2 Sig-
nificant cardiac comorbidity is generally considered a contra-
indication to LVRS. Untreated symptomatic severe aortic
stenosis, however, is associated with a poor prognosis.3 In
contrast, patients who undergo successful AVR for symp-
tomatic aortic stenosis experience a significant survival
benefit.3 Appropriate case selection allied with careful perio-
perative planning in this case resulted in QOL, functional,
pulmonary, and prognostic benefits. A multidisciplinary
approach was essential in providing an optimal outcome.
A skilled anesthetist was required to ensure proper place-
ment of the epidural catheter and double-lumen endotra-
cheal tube and intraoperative management of the patient.
An error in any of these areas could potentially lead to
severe consequences. The epidural catheter was placed 4
hours before scheduled surgery, as this strategy has been
shown to be safe despite full anticoagulation for CPB.4 A
satisfactory postoperative thoracic epidural analgesia con-
tributed to the patient’s good compliance with physiother-
apy and breathing exercises, thereby reducing the risks of
postoperative sputum retention and chest infection. Careful
anesthetic and intensive care management allowed for main-
tenance of cardiorespiratory stability and a successful
planned early extubation, thereby minimizing the risks asso-
ciated with mechanical ventilation. Daily medical manage-
ment by the chest physicians in the perioperative period
also ensured that the patient received optimal medical ther-
apy for her emphysema.Successful combined bilateral lung v
artery bypass grafting surgery: Imp
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sal of anticoagulation prior to LVRS ensured that there was
normal hemostasis during LVRS to minimize the risk of pul-
monary hemorrhage. We also found it useful to divide the
pleural adhesions while both lungs were deflated during
CPB. We felt that it was important to achieve satisfactory
cardiorespiratory stability and hemostasis before proceeding
with the LVRS. A bioprosthetic valve was placed as the pa-
tient did not want anticoagulation associated with a mechan-
ical valve. Although a tissue valve is not as durable as
a mechanical valve, patients with an FEV1<1 L have a mor-
tality rate of approximately 10% per year. It is probable that
a bioprosthetic valve may outlast the patient’s life expec-
tancy under these circumstances.5
In summary, careful perioperative planning and multidis-
ciplinary strategies ensured a successful concomitant LVRS
and AVR with satisfactory clinical outcome and marked
benefit for the patient.
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Coronary artery disease (CAD) is prevalent in patients
with severe emphysema who are being considered for
lung volume reduction surgery (LVRS).1 The National
Emphysema Treatment Trial excludes patients with a va-
riety of cardiovascular risk factors from undergoing
LVRS, as do many surgeons who perform the procedure
outside the trial.2 We describe a multidisciplinary ap-
proach that led to successful combined LVRS and coro-
nary artery bypass grafting (CABG) surgery and discuss
the implications and advantages relating to this combined
approach.
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